Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01823055
Other study ID # Karolinska Institutet
Secondary ID
Status Completed
Phase N/A
First received March 28, 2013
Last updated April 2, 2013
Start date January 2012

Study information

Verified date March 2013
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority Sweden: Institutional Review Board
Study type Interventional

Clinical Trial Summary

To perform a clinical safety and efficacy assessment of the Uphold LITE system for pelvic organ prolapse in a prospective multicenter, single cohort study.


Recruitment information / eligibility

Status Completed
Enrollment 214
Est. completion date
Est. primary completion date March 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older and present with primary or recurrent prolapse of the middle vaginal compartment corresponding to stage 2 or higher (according to the Pelvic Organ Prolapse Quantification [POP-Q] system)9,

- with or without anterior vaginal wall prolapse, and

- experiences symptoms of vaginal bulging with or without a previous hysterectomy

- being able to provide oral and written informed consent before entering the study.

Exclusion Criteria:

- previous cancer of any pelvic organ,

- systemic glucocorticoid treatment,

- insulin-treated diabetes,

- an inability to participate in study follow-up or to provide informed consent, or

- the need for any concomitant pelvic surgery.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Prolapse
  • Surgical Repair of Middle Compartment Prolapse (Vaginal Vault or Uterine Prolapse) With or Without Cystocele
  • Uterine Prolapse

Intervention

Procedure:
Transvaginal suture capturing mesh device
The Uphold™ LITE vaginal support system is an intra-vaginal approach to apical and anterior vaginal wall prolapse repair that utilizes a suture capturing device to place the mesh. After primary dissection the suturing device is used to pull the mesh through the sacrospinous ligament, medial to the ischial spine. An anterior colporraphy was allowed following the Uphold™ LITE procedure at the discretion of the surgeon if deemed necessary.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Karolinska Institutet Stockholm County Council, Karolinska Institutet research foundations, Swedish Society of Medicine, Boston Scientific

Outcome

Type Measure Description Time frame Safety issue
Primary Immediate and delayed complications related to the surgical procedure Serious surgical complications are categorised as any surgical event which is potentially life-threatening, internal organ perforation (or other injury), bleeding in excess of 1000 mL or adverse events, related to the surgical procedure, during follow-up which requires re-hospitalisation. 1 year Yes
Secondary Pelvic Organ Prolapse Quantification system The secondary efficacy outcome is a composite of objective and subjective measures including POP-Q stage 0 or 1 of the upper vaginal segment (i.e., point C/D, which represents the most distal point of the vaginal apex in relation to the total vaginal length) and a negative response to the question, "Do you experience a feeling of bulging or protrusion in the vaginal area?" (question 16 on the UDI). The secondary outcome measures further include the individual components of the composite end point, other POP-Q measurements and patient-reported urogenital distress. 1 year No